Common cancers in the elderly

Drugs and Aging

Volumn 13, Issue 6, 1998, Pages 467-478

  Hansen, Johnni ^a  

^a INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; COLON CANCER; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SKIN CANCER; SMOKING; SOCIOECONOMICS; STOMACH CANCER; TESTIS CANCER;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; PREVALENCE; REGISTRIES; SURVIVAL RATE;

EID: 0032438262     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199813060-00005     Document Type: Article

References (62)

1. Doll R. The age distribution of cancer: implications for models on carcinogenesis. J R Stat Soc Ser 1971; 134: 133-55
2. Cook P, Doll R, Fellingham SA. A mathematical model for the age distribution on cancer in man. Int J Cancer 1969; 4: 93-112
3. Yancik R, Ries LA. Cancer in older persons. Cancer 1994; 74: 1995-2003
4. Smith DWE. Circulatory disease mortality in the elderly. Epidemiology 1997; 8: 501-4
5. Muir CS, Nectoux J. International patterns of cancer. In: Schottenfeld D, Fraumeni Jr JF, editors. Cancer epidemiology and prevention. New York: Oxford University Press, 1996: 141-67
6. Wingo PA, Ries LAG, Rosenberg HM, et al. Cancer incidence and mortality, 1973-95. A report card for the US. Cancer 1998; 82: 1197-207
7. Hoel DG, Davis DL, Miller AB, et al. Trends in cancer mortality in 15 industrialized countries, 1969-1986. J Natl Cancer Inst 1992; 84: 313-20
8. Coebergh JW. Significant trends in cancer in the elderly. Eur J Cancer 1996; 32a: 569-71
9. Butler RN. Population aging and health. BMJ 1997; 315: 1082-4
10. Parkin DM, Whelan SL, Ferlay J, et al. IARC scientific publications: cancer incidence in five continents. Vol. VII. Lyon: International Agency for Research on Cancer (IARC), 1997
11. World Health Organization. International classification of diseases. 9th Rev. Geneva: WHO, 1977
12. Doll R, Payne P, Waterhouse J. Cancer incidence in five continents. Berlin: Springer-Verlag, 1966
13. Segi M. Cancer mortality for selected sites in 24 countries (1950-57). Sendai: Tohoku University of Public Health, 1960
14. Jensen OM, Parkin DM, MacLennan R, et al. IARC scientific publications: cancer registration principles and methods. Lyon: International Agency for Research on Cancer (IARC), 1991
15. Balducci L, Pow Sang J, Friedland J, et al. Prostate cancer. Clin Geriatr Med 1997; 13: 283-306
16. Merrill RM, Brawley OW. Prostate cancer incidence and mortality rates among white and black men. Epidemiology 1997; 8: 126-31
17. Merrill RM, Weed DL, Feuer EJ. The lifetime risk of developing prostate cancer in white and black men. Cancer Epidemiol Biomarkers Prev 1997; 6: 763-8
18. Potosky AL, Kessler L, Gridley G, et al. Rise in prostatic cancer incidence associated with increase use of transurethral resection. J Natl Cancer Inst 1990; 82: 1624-8
19. Rohr LR. Incidental adenocarcinoma in transurethral resections of the prostate: partial versus complete microscopic examination. Am J Surg Pathol 1987; 11: 53-8
20. Potosky AL, Miller BA, Albertsen PC, et al. The role of increasing detection in the rising incidence of prostate cancer. JAMA 1995; 273: 548-52
21. Mettlin C. Changes in patterns of prostate cancer care in the United States: results of American College of Surgeons Commission on Cancer studies, 1974-1993. Prostate 1997; 32: 221-6
22. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 1993; 54: 594-606
23. Adami HO, Adams G, Boyle P, et al. Breast-cancer etiology. Int J Cancer 1990; Suppl. 5: 22-39
24. Boyle P, Leake R. Progress in understanding breast cancer: epidemiological and biological interactions. Breast Cancer Res Treat 1988; 11: 91-112
25. Kelsey JL, Berkowitz GS. Breast-cancer epidemiology. Cancer Res 1988; 48: 5615-23
26. Balducci L, Silliman RA, Baekey P. Breast cancer: an oncological perspective. Pt 1. In: Balducci L, Lyman GH, William BE, editors. Comprehensive geriaric oncology. Amsterdam: Harwood Academic Publishers, 1997: 629-60
27. Caplan LS. Disparities in breast cancer screening: is it ethical? Public Health Rev 1997; 25: 31-41
28. Trontell AE, Franey EW. Use of mammography services by women aged >65 years enrolled in Medicare - United States, 1991-1993 [abstract]. JAMA 1995; 274: 1420
29. Hansen J, Olsen JH. Respiratory system: nasal cavities and sinuses, larynx, lung, pleura. Acta Pathol Microbiol Scand 1993; 100 Suppl. 33: 77-98
30. Doll R. Major epidemics of the 20th century from coronary thrombosis to AIDS. J R Stat Soc 1987; 150: 373-95
31. Levi F, Vecchia CL, Lucchini F, et al. Worldwide trends in cancer mortality in the eldery, 1955-1992. Eur J Cancer 1996; 32a: 652-72
32. McMichael AJ, Potter JD. Reproduction, endogenous and exogenous sex hormones, and colon cancer: a review and hypothesis. J Natl Cancer Inst 1980; 65: 1201-7
33. Potter JD, Slattery ML, Bostick RM, et al. Colon cancer: a review of the epidemiology. Epidemiol Rev 1993; 15: 499-545
34. Sian MS. Diet and nutritional factors in the aetiology of colon cancer [review]. Anticancer Res 1987; 7: 293-300
35. van Loon AJ, Burg J, Goldbohm RA, et al. Differences in cancer incidence and mortality among socio-economic groups. Scand J Soc Med 1995; 23: 110-20
36. Williams J, Clifford C, Hopper J, et al. Socioeconomic status and cancer mortality and incidence in Melbourne. Eur J Cancer 1991; 27: 917-21
37. Howson CP, Hiyama T, Wynder RL. The decline in gastric cancer: epidemiology of an unplanned triumph. Epidemiol Rev 1986; 8: 1-27
38. Cordle F. The use of epidemiology, scientific data, and regulatory authority to determinate risk factors in cancers of some organs of the digestive system: 5. stomach cancer. Regul Toxicol Pharmacol 1986; 6: 171-80
39. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans: hepatitis viruses. Lyon: International Agency for Research on Cancer (IARC), 1994; 1-286
40. Benhamiche AM, Faivre J, Tazi AM, et al. Time trends in diagnostic strategy, treatment, and prognosis of gastric cancer in the elderly: a population based study. Eur J Cancer Prev 1997; 6: 71-7
41. Smith DWE. Cancer mortality at very old ages. Cancer 1996; 77: 1367-72
42. Stanta G, Campagner L, Cavallieri F, et al. Cancer of the oldest old: what we have learned from autopsy studies. Clin Geriatr Med 1997; 13: 55-68
43. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. J Natl Cancer Inst 1981; 66: 1192-308
44. International Agency for Research on Cancer: IARC Monographs on the evaluation of carcinogenic risks to humans: tobacco smoking. Vol. 37. Lyon: International Agency for Research on Cancer (IARC), 1986
45. International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans: schistosomes, liver flukes and heliobacter pylori. Lyon: International Agency for Research on Cancer (IARC), 1994; 1-270
46. Cameron HM, McGoogan E. A prospective study of 1152 hospital autopsies: 1. inaccuracies in death certification. J Pathol 1981; 133: 273-83
47. Cameron HM, McGoogan E, Watson H. Necropsy: a yardstick for clinical diagnoses. BMJ 1980; 281: 985-8
48. Berrino F, Sant M, Verdecchia A, et al. IARC Scientific Publications: survival of cancer patients in Europe: the Eurocare study. Lyon: International Agency for Research on Cancer (IARC), 1995
49. Ries LAG, Hankey BF, Harras A, et al. Cancer incidence, mortality, and patient survival in the United States. In: Schottenfeld D, Fraumeni Jr JF, editors. Cancer epidemiology and prevention. New York: Oxford University Press, 1996: 168-91
50. Havlik RJ, Yancik R, Long S, et al. The National Institute on Aging and the National Cancer Institute SEER collaborative study on comorbidity and early diagnosis of cancer in the elderly. Cancer 1994; 74: 2101-6
51. Yancik R, Havlik RJ, Wesley MN, et al. Cancer and comorbidity in older patients: a descriptive profile. Ann Epidemiol 1996; 6: 399-412
52. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994; 120: 104-10
53. Kant AK, Glover C, Horm J, et al. Does cancer survival differ for older patients? Cancer 1992; 70: 2734-40
54. Samet J, Hunt WC, Key C, et al. Choice of cancer therapy varies with age of patient. JAMA 1986; 255: 3385-90
55. Mor V, Masterson Allen S, Goldberg RJ, et al. Relationship between age at diagnosis and treatments received by cancer patients. J Am Geriatr Soc 1985; 33: 585-9
56. Goodwin JS, Samet JM, Key CR, et al. Stage at diagnosis of cancer varies with the age of the patient. J Am Geriatr Soc 1986; 34: 20-6
57. Holmes FF, Weyandt T, Glazier J, et al. Fulminant Meningococcemia after splenectomy. JAMA 1981; 246: 1119-20
58. Samet JM, Hunt WC, Goodwin JS. Determinants of stage and size of cancer in the elderly New Mexicans: a population based study. Cancer 1990; 46: 1302-7
59. Doll R, Fraumeni Jr JF, Muir CS. Cancer surveys: trends in cancer incidence and mortally. New York: Cold Spring Harbor Laboratory Press, 1994; 1-583
60. Polednak AP. Estimating the prevalence of cancer in the United States. Cancer 1997; 80: 136-41
61. Micheli A, Gatta G, Verdecchia A. Studying survival of cancer patients in different populations: its potential and role. Tumori 1997; 83: 3-8
62. National Board of Health. Sundhedsstatistikken: Cancer incidence i Denmark 1994. Copenhagen: The Danish National Board of Health, 1998; 1-96